In a separate analysis of MTBP protein expression by immunohistochemistry in 112 lung adenocarcinoma patient samples spanning stage I to stage IV disease, “hyper-expression” of MTBP was observed in 23.21% of samples [9]. The gene discussed is MTBP; the disease is lung adenocarcinoma.